Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3

Summary

The current study will assess the acceptability and feasibility of the CareMeds intervention with a larger sample (N = 100) across multiple sites in Buffalo, NY, and Atlanta, GA.

Eligibility

Inclusion Criteria:

* Parent of a child who is diagnosed and being treated for any type of acute lymphoblastic leukemia (ALL) at a study site.
* Parent has primary medication responsibility.
* Pediatric patient aged 3-9 years
* Child on therapy that includes home-based oral anti-cancer medication taken at home, such as 6-MP.
* Parent has verbal English or Spanish fluency.
* Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure

Exclusion Criteria:

* Parent of a child who is not diagnosed nor being treated for any type of acute lymphoblastic leukemia (ALL) at a study site.
* Parent does not have primary medication responsibility.
* Pediatric patient aged 3-9 years
* Pediatric patient is not on therapy that includes oral anti-cancer medication (e.g., 6-MP).
* Parent does not have verbal English or Spanish fluency.
* Parent is unwilling or unable to follow protocol requirements

Conditions2

Locations1 site

Browse More Trials